BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Immune Tolerance

Below is an extended Immune Tolerance research listing. Click here to return to the Immune Tolerance main in depth entry.

Recent Publications on Immune Tolerance:

The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation.
Regulatory T cells (Treg) are critical regulators of immune tolerance....
Direct Link
3rd October, 2008
Diabetes Center, Department of Medicine, University of California San
NKT cell development in the absence of the autoimmune regulator gene (Aire).
Autoimmune regulator gene (Aire)-deficient mice develop an array of...
Direct Link
2nd October, 2008
Department of Microbiology and Immunology, University of Melbourne,
P38 MAP kinase signaling is required for the conversion of CD4+CD25- T cells into iTreg.
CD4+CD25+ regulatory T cells (Treg) are important mediators of immune...
Direct Link
2nd October, 2008
I. Medizinische Klinik, Universitatsklinikum Hamburg-Eppendorf, Hamburg,
Emergence of hormonal and redox regulation of galectin-1 in placental mammals: Implication in maternal-fetal immune tolerance.
Galectin-1 is an anti-inflammatory lectin with pleiotropic regulatory...
Direct Link
1st October, 2008
Perinatology Research Branch, National Institute of Child Health and Human
Immunosuppressive regulatory T cells are associated with aggressive breast cancer phenotypes: a potential therapeutic target.
FoxP3 is a marker for immunosuppressive CD25+CD4+ regulatory T cells....
Direct Link
30th September, 2008
1Department of Anatomic Pathology, University of Washington Medical
How we treat a hemophilia A patient with a factor VIII inhibitor.
The most significant complication of treatment in patients with hemophilia...
Direct Link
30th September, 2008
Aflac Cancer Center and Blood Disorders Service and Winship Cancer
[Pretreatment of donor dendritic cells with NBD-peptide prolongs mouse cardiac allograft survival.] 30th September, 2008
Department of Cardiovascular Surgery, First Affiliated Hospital of
[The immune system and the eye] 30th September, 2008
Kobenhavns Universitet, Panum Instituttet, Det Sundhedsvidenskabelige
Induction of immune tolerance by activation of CD8(+) T suppressor/regulatory cells in lupus-prone mice.
Multiple CD8(+) suppressive T cell (Ts) subtypes are now recognized as...
Direct Link
27th September, 2008
Division of Rheumatology, David Geffen School of Medicine, University of
CD8(+) regulatory T cells, their suppressive mechanisms, and regulation in cancer.
Regulatory T (Treg) cells induce immune tolerance by suppressing host...
Direct Link
27th September, 2008
Center for Cell and Gene Therapy, Departments of Pathology and Immunology,
Immune modulation and chronic graft-versus-host disease.
As more and more patients undergoing allogeneic hematopoietic SCT (HSCT)...
Direct Link
25th September, 2008
Division of Hematologic Malignancies, Dana Farber Cancer Institute,
Clinical practice. Food allergy.
BACKGROUND: Preeclampsia origin has no conclusive explanation. As part of...
Direct Link
25th September, 2008
Department of Paediatric Allergy, King's College London, and the
Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific Tregs.
Tregs are important mediators of immune tolerance to self antigens, and it...
Direct Link
20th September, 2008
Department of Medicine I, University Medical Center Hamburg-Eppendorf,
[Lymphocyte subsets and preeclampsia] 20th September, 2008
Centro Medico Nacional de Occidente, UMAE, Hospital de Especialidades,
Extracorporeal photopheresis normalizes some lymphocyte subsets (including T regulatory cells) in chronic graft-versus-host-disease.
Extracorporeal photopheresis (ECP) has been demonstrated to be clinically...
Direct Link
16th September, 2008
Photopheresis Unit, Rotherham General Hospital, Rotherham, UK.
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional